Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DEXCOM INCDXCM · Entity 3114 | EVP Global Marketing | May 09, 2022 | May 10, 2022 |
| iRhythm Holdings, Inc.IRTC · Entity 1499 | CHIEF COMM & PRODUCT OFFICER | August 07, 2026 | August 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DEXCOM INC
Report date May 09, 2022 · Filed May 10, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 13,675 |
Reported balance
After 2022-05-09 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-05-09 · Sale · Disposed 777 · Balance 13,675 F1: On June 14, 2021, Mr. Patterson adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Patterson. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2: Included in this number are 13,675 unvested restricted stock units, 5,297 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,925 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 3,756 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,697 of which were granted on March 8, 2020 and shall vest through March 8, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: On June 14, 2021, Mr. Patterson adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Patterson. The shares set forth above were sold pursuant to the 10b5-1 Plan.
F2: Included in this number are 13,675 unvested restricted stock units, 5,297 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,925 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 3,756 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,697 of which were granted on March 8, 2020 and shall vest through March 8, 2023.
iRhythm Holdings, Inc.
Report date August 07, 2026 · Filed August 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 62,125 |
Ending reported balance
After 2026-08-10 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-08-07 · Grant · Acquired 13,589 · Balance 69,218 F1: Represents the acquisition of shares upon the determination of the Compensation & Human Capital Management Committee of the Board of Directors of the Issuer that the performance conditions were met with respect to performance Restricted Stock Units ("RSUs") granted to the Reporting Person on August 7, 2023. Row 2 · 2026-08-10 · Sale · Disposed 7,093 · Balance 62,125 F2: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of performance RSUs. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the acquisition of shares upon the determination of the Compensation & Human Capital Management Committee of the Board of Directors of the Issuer that the performance conditions were met with respect to performance Restricted Stock Units ("RSUs") granted to the Reporting Person on August 7, 2023.
F2: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of performance RSUs.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 10, 2026 Filed Aug 11, 2026 20:01 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | SaleCommon Stock | 7,093 | $124.65 | $884,170.11 |
DisclosureSEC source: 0001850152-26-000012 · wk-form4_1786478507.xml · nonDerivative · entry 2 Patterson Chad · CIK 0001850152 · CHIEF COMM & PRODUCT OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,125 F2 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of performance RSUs. Read SEC document |
| August 07, 2026 Filed Aug 11, 2026 20:01 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | GrantCommon Stock | 13,589 | $0.00 | $0.00 |
DisclosureSEC source: 0001850152-26-000012 · wk-form4_1786478507.xml · nonDerivative · entry 1 Patterson Chad · CIK 0001850152 · CHIEF COMM & PRODUCT OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,218 F1 · shares: Represents the acquisition of shares upon the determination of the Compensation & Human Capital Management Committee of the Board of Directors of the Issuer that the performance conditions were met with respect to performance Restricted Stock Units ("RSUs") granted to the Reporting Person on August 7, 2023. Read SEC document |
| August 03, 2026 Filed Aug 4, 2026 20:01 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | SaleCommon Stock | 2,712 | $122.12 | $331,191.88 |
DisclosureSEC source: 0001850152-26-000010 · wk-form4_1785873670.xml · nonDerivative · entry 1 Patterson Chad · CIK 0001850152 · CHIEF COMM & PRODUCT OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,629 F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs). Read SEC document |
| May 29, 2026 Filed Jun 1, 2026 20:34 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | GrantCommon Stock | 177 | $96.82 | $17,136.26 |
DisclosureSEC source: 0001850152-26-000008 · wk-form4_1780346050.xml · nonDerivative · entry 1 Patterson Chad · CIK 0001850152 · CHIEF COMM & PRODUCT OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,341 F1 · shares: Mr. Patterson is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2016 Employee Stock Purchase Plan for the purchase period December 1, 2025 through May 31, 2026. This transaction is exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 23:37 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | SaleCommon Stock | 3,030 | $128.44 | $389,188.05 |
DisclosureSEC source: 0001850152-26-000006 · wk-form4_1772581019.xml · nonDerivative · entry 2 Patterson Chad · CIK 0001850152 · CHIEF COMM & PRODUCT OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,164 F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs). Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 23:37 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | SaleCommon Stock | 1,414 | $128.44 | $181,616.14 |
DisclosureSEC source: 0001850152-26-000006 · wk-form4_1772581019.xml · nonDerivative · entry 1 Patterson Chad · CIK 0001850152 · CHIEF COMM & PRODUCT OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,194 F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs). Read SEC document |
| February 25, 2026 Filed Feb 26, 2026 22:38 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | SaleCommon Stock | 8,967 | $135.42 | $1,214,301.28 |
DisclosureSEC source: 0001850152-26-000002 · wk-form4_1772145504.xml · nonDerivative · entry 2 Patterson Chad · CIK 0001850152 · CHIEF COMM & PRODUCT OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,738 F2 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of performance RSUs. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:41 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | GrantCommon Stock | 10,870 | $0.00 | $0.00 |
DisclosureSEC source: 0001850152-26-000004 · wk-form4_1772228463.xml · nonDerivative · entry 1 Patterson Chad · CIK 0001850152 · CHIEF COMM & PRODUCT OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,608 F1 · shares: These securities are Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs vest on March 1, 2027 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 22:38 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | GrantCommon Stock | 17,318 | $0.00 | $0.00 |
DisclosureSEC source: 0001850152-26-000002 · wk-form4_1772145504.xml · nonDerivative · entry 1 Patterson Chad · CIK 0001850152 · CHIEF COMM & PRODUCT OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,705 F1 · shares: Represents the acquisition of shares upon the determination of the Compensation & Human Capital Management Committee of the Board of Directors of the Issuer that the performance conditions were met with respect to performance Restricted Stock Units ("RSUs") granted to the Reporting Person on February 27, 2023. Read SEC document |
| December 02, 2025 Filed Dec 3, 2025 21:35 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | SaleCommon Stock | 280 | $184.83 | $51,752.40 |
DisclosureSEC source: 0001850152-25-000007 · wk-form4_1764797755.xml · nonDerivative · entry 1 Patterson Chad · CIK 0001850152 · CHIEF COMM & PRODUCT OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,387 F1 · shares: This transaction represents the sale of common stock originally acquired by the reporting person pursuant to the Issuer's Employee Stock Purchase Plan effected through a 10b5-1 plan. Read SEC document |
| August 06, 2025 Filed Aug 7, 2025 20:57 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | SaleCommon Stock | 2,555 | $158.97 | $406,168.35 |
DisclosureSEC source: 0001850152-25-000005 · wk-form4_1754600252.xml · nonDerivative · entry 1 Patterson Chad · CIK 0001850152 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,667 F1 · shares: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on November 25, 2024. Read SEC document |
| August 04, 2025 Filed Aug 5, 2025 21:02 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | SaleCommon Stock | 2,707 | $164.36 | $444,921.71 |
DisclosureSEC source: 0001388658-25-000199 · wk-form4_1754427734.xml · nonDerivative · entry 1 Patterson Chad · CIK 0001850152 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,222 F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of RSUs. Read SEC document |
| June 23, 2025 Filed Jun 24, 2025 20:15 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | SaleCommon Stock | 936 | $150.00 | $140,400.00 |
DisclosureSEC source: 0001388658-25-000162 · wk-form4_1750796127.xml · nonDerivative · entry 1 Patterson Chad · CIK 0001850152 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 48,929 F1 · shares: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on November 25, 2024. Read SEC document |
| June 10, 2025 Filed Jun 11, 2025 20:21 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | SaleCommon Stock | 363 | $150.00 | $54,450.00 |
DisclosureSEC source: 0001388658-25-000158 · wk-form4_1749673286.xml · nonDerivative · entry 1 Patterson Chad · CIK 0001850152 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 49,865 F1 · shares: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on November 25, 2024. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 20:16 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | GrantCommon Stock | 298 | $71.46 | $21,295.08 |
DisclosureSEC source: 0001388658-25-000154 · wk-form4_1748981789.xml · nonDerivative · entry 1 Patterson Chad · CIK 0001850152 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,228 F1 · shares: Mr. Patterson is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2016 Employee Stock Purchase Plan for the purchase period December 1, 2024 through May 31, 2025. This transaction is exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| May 02, 2025 Filed May 5, 2025 20:10 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | SaleCommon Stock | 1,300 | $125.00 | $162,500.00 |
DisclosureSEC source: 0001388658-25-000109 · wk-form4_1746475828.xml · nonDerivative · entry 2 Patterson Chad · CIK 0001850152 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,930 F1 · shares: Shares sold pursuant to a 10b5-1 trading plan. Read SEC document |
| May 02, 2025 Filed May 5, 2025 20:10 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | SaleCommon Stock | 7,210 | $119.75 | $863,397.50 |
DisclosureSEC source: 0001388658-25-000109 · wk-form4_1746475828.xml · nonDerivative · entry 1 Patterson Chad · CIK 0001850152 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,230 F1 · shares: Shares sold pursuant to a 10b5-1 trading plan. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 21:03 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | SaleCommon Stock | 2,756 | $108.77 | $299,770.12 |
DisclosureSEC source: 0001388658-25-000064 · wk-form4_1741122207.xml · nonDerivative · entry 1 Patterson Chad · CIK 0001850152 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,440 F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units. Read SEC document |
| February 26, 2025 Filed Feb 27, 2025 21:08 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | SaleCommon Stock | 13,229 | $112.13 | $1,483,367.77 |
DisclosureSEC source: 0001388658-25-000052 · wk-form4_1740690527.xml · nonDerivative · entry 5 Patterson Chad · CIK 0001850152 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,196 F5 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of performance RSUs. Read SEC document |
| February 26, 2025 Filed Feb 27, 2025 21:08 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | GrantCommon Stock | 12,118 | $0.00 | $0.00 |
DisclosureSEC source: 0001388658-25-000052 · wk-form4_1740690527.xml · nonDerivative · entry 4 Patterson Chad · CIK 0001850152 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,425 F4 · shares: These securities are RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs vest on March 1, 2026 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 21:08 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | GrantCommon Stock | 25,546 | $0.00 | $0.00 |
DisclosureSEC source: 0001388658-25-000052 · wk-form4_1740690527.xml · nonDerivative · entry 3 Patterson Chad · CIK 0001850152 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,307 F3 · shares: Represents the acquisition of shares upon the determination of the Compensation Committee of the Board of Directors of the Issuer that the performance conditions were met with respect to performance Restricted Stock Units ("RSUs") granted to the Reporting Person on July 25, 2022. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 21:08 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | SaleCommon Stock | 461 | $118.98 | $54,849.78 |
DisclosureSEC source: 0001388658-25-000052 · wk-form4_1740690527.xml · nonDerivative · entry 2 Patterson Chad · CIK 0001850152 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,761 F2 · shares: This transaction represents the sale of common stock originally acquired by the reporting person pursuant to the Issuer's Employee Stock Purchase Plan effected through a 10b5-1 plan. Read SEC document |
| August 02, 2024 Filed Aug 5, 2024 21:35 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | SaleCommon Stock | 3,012 | $74.66 | $224,875.92 |
DisclosureSEC source: 0001388658-24-000147 · wk-form4_1722893711.xml · nonDerivative · entry 2 Patterson Chad · CIK 0001850152 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,133 F2 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units. Read SEC document |
| May 31, 2024 Filed Aug 5, 2024 21:35 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | PurchaseCommon Stock | 280 | $74.98 | $20,994.40 |
DisclosureSEC source: 0001388658-24-000147 · wk-form4_1722893711.xml · nonDerivative · entry 1 Patterson Chad · CIK 0001850152 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,145 F1 · shares: Includes 280 shares acquired under the Issuer's employee stock purchase plan on May 31, 2024 in transactions that were exempt under Rules 16b-3(c) and 16b-3(d). Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 21:52 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | SaleCommon Stock | 1,077 | $111.14 | $119,697.78 |
DisclosureSEC source: 0001388658-24-000060 · wk-form4_1709675527.xml · nonDerivative · entry 1 Patterson Chad · CIK 0001850152 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,865 F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units. Read SEC document |
| February 28, 2024 Filed Mar 2, 2024 00:19 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | GrantCommon Stock | 10,742 | $0.00 | $0.00 |
DisclosureSEC source: 0001388658-24-000045 · wk-form4_1709338758.xml · nonDerivative · entry 1 Patterson Chad · CIK 0001850152 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,942 F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs vest on February 28, 2025 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| November 30, 2023 Filed Feb 27, 2025 21:08 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | OtherCommon Stock | 89 | $72.49 | $6,451.61 |
DisclosureSEC source: 0001388658-25-000052 · wk-form4_1740690527.xml · nonDerivative · entry 1 Patterson Chad · CIK 0001850152 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,222 F1 · shares: Mr. Patterson is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2016 Employee Stock Purchase Plan for the purchase period December 1, 2022 through November 30, 2023. This transaction is exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 02, 2023 Filed Aug 2, 2023 22:46 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | SaleCommon Stock | 1,896 | $100.49 | $190,529.04 |
DisclosureSEC source: 0001388658-23-000097 · wk-form4_1691016361.xml · nonDerivative · entry 1 Patterson Chad · CIK 0001850152 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,200 F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of RSUs. F2 · balance_after: Includes 372 shares acquired under the Issuer's employee stock purchase plan on May 31, 2023 Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 23:22 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | GrantCommon Stock | 10,674 | $0.00 | $0.00 |
DisclosureSEC source: 0001388658-23-000024 · wf-form4_167771293772216.xml · nonDerivative · entry 1 Patterson Chad · CIK 0001850152 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,724 F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs vest on March 1, 2024 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| July 25, 2022 Filed Jul 27, 2022 20:16 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | GrantCommon Stock | 20,789 | $0.00 | $0.00 |
DisclosureSEC source: 0001388658-22-000117 · wf-form4_165895297176854.xml · nonDerivative · entry 1 Patterson Chad · CIK 0001850152 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,789 F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs vest on August 1, 2023 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| July 25, 2022 Filed Nov 21, 2022 16:01 UTC Amendment | iRhythm Holdings, Inc. IRTC · Entity 1499 | GrantCommon Stock | 21,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001388658-22-000161 · wf-form4a_166904644984279.xml · nonDerivative · entry 1 Patterson Chad · CIK 0001850152 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,050 F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs vest on August 1, 2023 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date. F2 · acquired: The acquisition of 261 shares was omitted from the Reporting Person's original Form 4, filed July 27, 2022. Read SEC document |
| May 09, 2022 Filed May 10, 2022 20:11 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 777 | $342.77 | $266,332.29 |
DisclosureSEC source: 0001093557-22-000102 · edgardoc.xml · nonDerivative · entry 1 Patterson Chad · CIK 0001850152 · EVP Global Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,675 F1 · shares: On June 14, 2021, Mr. Patterson adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Patterson. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 13,675 unvested restricted stock units, 5,297 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,925 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 3,756 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,697 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| April 11, 2022 Filed Apr 13, 2022 20:43 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 776 | $498.75 | $387,030.00 |
DisclosureSEC source: 0001093557-22-000088 · edgardoc.xml · nonDerivative · entry 1 Patterson Chad · CIK 0001850152 · EVP, Global Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,452 F1 · shares: On June 14, 2021, Mr. Patterson adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Patterson. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 13,675 unvested restricted stock units, 5,297 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,925 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 3,756 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,697 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 20:22 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 776 | $401.27 | $311,385.52 |
DisclosureSEC source: 0001093557-22-000061 · edgardoc.xml · nonDerivative · entry 1 Patterson Chad · CIK 0001850152 · EVP, Global Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,228 F1 · shares: On June 14, 2021, Mr. Patterson adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Patterson. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 13,675 unvested restricted stock units, 5,297 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,925 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 3,756 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,697 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 00:27 UTC | DEXCOM INC DXCM · Entity 3114 | Disposition to issuerCommon Stock | 974 | $406.06 | $395,499.23 |
DisclosureSEC source: 0001093557-22-000051 · edgardoc.xml · nonDerivative · entry 5 Patterson Chad · CIK 0001850152 · EVP, Global Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,004 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 13,675 unvested restricted stock units, 5,297 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,925 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 3,756 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,697 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 00:27 UTC | DEXCOM INC DXCM · Entity 3114 | Disposition to issuerCommon Stock | 223 | $406.06 | $90,550.64 |
DisclosureSEC source: 0001093557-22-000051 · edgardoc.xml · nonDerivative · entry 4 Patterson Chad · CIK 0001850152 · EVP, Global Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,978 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 13,675 unvested restricted stock units, 5,297 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,925 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 3,756 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,697 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 00:27 UTC | DEXCOM INC DXCM · Entity 3114 | Disposition to issuerCommon Stock | 432 | $406.06 | $175,416.49 |
DisclosureSEC source: 0001093557-22-000051 · edgardoc.xml · nonDerivative · entry 3 Patterson Chad · CIK 0001850152 · EVP, Global Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,201 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 13,675 unvested restricted stock units, 5,297 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,925 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 3,756 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,697 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 00:27 UTC | DEXCOM INC DXCM · Entity 3114 | Disposition to issuerCommon Stock | 192 | $406.06 | $77,962.89 |
DisclosureSEC source: 0001093557-22-000051 · edgardoc.xml · nonDerivative · entry 2 Patterson Chad · CIK 0001850152 · EVP, Global Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,633 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 13,675 unvested restricted stock units, 5,297 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,925 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 3,756 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,697 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 08, 2022 Filed Mar 11, 2022 00:27 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 5,297 | $0.00 | $5.30 |
DisclosureSEC source: 0001093557-22-000051 · edgardoc.xml · nonDerivative · entry 1 Patterson Chad · CIK 0001850152 · EVP, Global Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,825 F1 · shares: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock. F2 · balance_after: Included in this number are 13,675 unvested restricted stock units, 5,297 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,925 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 3,756 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,697 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 21:42 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 46 | $413.97 | $19,042.62 |
DisclosureSEC source: 0001093557-22-000023 · edgardoc.xml · nonDerivative · entry 1 Patterson Chad · CIK 0001850152 · EVP, Global Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,528 F1 · shares: On June 14, 2021, Mr. Patterson adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Patterson. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 12,528 unvested restricted stock units, 2,925 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,394 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 575 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 21:40 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 2,925 | $0.00 | $2.93 |
DisclosureSEC source: 0001093557-21-000288 · edgardoc.xml · nonDerivative · entry 1 Patterson Chad · CIK 0001850152 · EVP, Global Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,528 F1 · shares: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting over a 36 month period from the date of grant as follows: 1/2 shall vest 24 months from the Grant Date, 1/8 shall vest 27 months from the Grant Date, 1/8 shall vest 30 months from the grant date, 1/8 shall vest 33 months from the Grant Date, and the remaining balance shall vest 36 months from the Grant Date. Share units represent a contingent right to receive one share of DexCom Inc. Common Stock. F2 · balance_after: Included in this number are 12,528 unvested restricted stock units, 2,925 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,394 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 575 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| October 13, 2021 Filed Oct 15, 2021 23:13 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 141 | $545.54 | $76,921.14 |
DisclosureSEC source: 0001093557-21-000237 · edgardoc.xml · nonDerivative · entry 1 Patterson Chad · CIK 0001850152 · EVP, Global Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,603 F1 · shares: On June 14, 2021, Mr. Patterson adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Patterson. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 9,603 unvested restricted stock units, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,394 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 575 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 20:14 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 156 | $541.47 | $84,469.32 |
DisclosureSEC source: 0001093557-21-000229 · edgardoc.xml · nonDerivative · entry 1 Patterson Chad · CIK 0001850152 · EVP, Global Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,744 F1 · shares: On June 14, 2021, Mr. Patterson adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Patterson. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 9,603 unvested restricted stock units, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,394 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 575 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| September 09, 2021 Filed Sep 14, 2021 00:00 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 4 | $542.02 | $2,168.09 |
DisclosureSEC source: 0001093557-21-000217 · edgardoc.xml · nonDerivative · entry 2 Patterson Chad · CIK 0001850152 · EVP, Global Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,900 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 9,603 unvested restricted stock units, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,394 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 575 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| September 09, 2021 Filed Sep 14, 2021 00:00 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 287 | $541.36 | $155,370.32 |
DisclosureSEC source: 0001093557-21-000217 · edgardoc.xml · nonDerivative · entry 1 Patterson Chad · CIK 0001850152 · EVP, Global Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,904 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 9,603 unvested restricted stock units, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,394 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 575 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.